This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Trading, Loan Growth to Support JPMorgan's (JPM) Q4 Earnings
by Zacks Equity Research
Decent trading activities, higher rates and modest loan growth will likely aid JPMorgan's (JPM) Q4 results, while dismal investment banking and rise in expenses are expected to be on the downside.
Can Earnings Reports Push Bank Stocks Higher?
by Sheraz Mian
On most key operating metrics, bank performance has been very strong in the first three quarters of the year and most of those favorable trends will show up in the Q4 results as well.
Oracle Grabs San Francisco Ballpark's Naming Rights for 20 Years
by Zacks Equity Research
Oracle (ORCL) is reportedly purchasing the naming rights of San Francisco, CA-based baseball stadium, home to the Giants.
Citi (C) to Sell Entire Stake in Chinese Securities Venture
by Zacks Equity Research
Citigroup (C) is looking to sell its entire stake in Chinese securities venture, Citi Orient Securities Co Joint venture, reports Reuters.
JPMorgan Chase (JPM) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
JP Morgan (JPM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Trade Talks and Oil Price Rebound to Boost Wall Street
by Zacks Equity Research
Trade Talks and Oil Price Rebound to Boost Wall Street
Much Ado About Trade Talks with China
by Mark Vickery
It's tough to consider this recent "happy talk" on China/U.S. trade to be justified, but at least it's better than the alternative.
EU Nears Imposing Stricter Rules on Investment Managers
by Zacks Equity Research
Investment management companies will be subject to supervision by the European Central Bank. Also, the companies will be required to distribute their assets both inside and outside of the eurozone.
Dogs of the Dow Win in 2018: Will ETFs See Success in 2019?
by Sanghamitra Saha
Dogs of the Dow beat the broader market in 2018. Will Dogs ETFs be able to taste success this year too?
Should iShares Morningstar Large-Cap Value ETF (JKF) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JKF
JPMorgan Chase (JPM) Gains But Lags Market: What You Should Know
by Zacks Equity Research
In the latest trading session, JPMorgan Chase (JPM) closed at $100.76, marking a +0.07% move from the previous day.
Apple, JPMorgan and Wells Fargo are part of Zacks Earnings Preview
by Zacks Equity Research
Apple, JPMorgan and Wells Fargo are part of Zacks Earnings Preview
The Market's Earnings Uncertainty
by Sheraz Mian
Earnings estimates for 2018 Q4 and full-year 2019 have been coming down lately, but they likely have even more room to go down given the headwinds.
Has the Trade Debacle Ended for US MedTech Space? 3 Picks
by Sreyoshi Mukherjee
As the trade war fears slowly dissipate, let's take a look at three profitable U.S. MedTech picks.
Value Investors Avoid JPM, Buy These 5 Bank Stocks Instead
by Swayta Shah
While JPMorgan (JPM) doesn't seem to be a value pick right now, there are a few bank stocks that investors can bet on based on favorable Zacks Rank and strong prospects.
First Republic (FRC) Announces Offering of 4M Common Shares
by Zacks Equity Research
First Republic (FRC) expects to use proceeds from the offering for funding loans and building its portfolio.
JPMorgan Chase (JPM) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
JPMorgan Chase (JPM) closed at $97.04 in the latest trading session, marking a +1.13% move from the prior day.
Can Oil Prices Rebound in 2019? 5 Top-Ranked Picks
by Swarup Gupta
Fresh production curbs from OPEC and its allies will begin to have an impact on crude supplies, aided by Canada.
JPMorgan Settles Improper Handling of ADRs Charges for $135M
by Zacks Equity Research
Resolution of past business misconduct allegations is a step in the right direction for JPMorgan (JPM).
5 Great Healthcare Stocks to Buy for 2019
by Swarup Gupta
Rapid innovation, major advances and an ageing population have managed to sustain the popularity of healthcare stocks.
Can Living Wills Enable Foreign Banks to Overcome Drawbacks?
by Zacks Equity Research
Per the banking regulators, the 'Living Wills' of U.S. divisions of four foreign banks have significantly improved, driven by reduced size and risk profiles.
PayPal (PYPL) Stock Looks Like a Buy Heading Into the New Year
by Benjamin Rains
Shares of PayPal (PYPL) are still up roughly 10% over the past year despite a ton of turbulence. So, let's see why the financial tech firm's stock looks like a buy heading into 2019 in an industry that is only set to grow.
Here's Why You Should Buy Square (SQ) Stock on the Dip Heading into 2019
by Benjamin Rains
Square (SQ) stock climbed early Wednesday, before it eventually fell, after reports surfaced that the financial tech firm has restarted efforts to open its own bank. With that said, Square stock is down over 30% in the past three months, which could set up a solid buying opportunity for those high on the fintech power that looks poised for serious top and bottom line growth.
JPMorgan Chase (JPM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, JPMorgan Chase (JPM) closed at $98.54, marking a -0.47% move from the previous day.
Should WisdomTree U.S. Earnings 500 Fund (EPS) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for EPS